Inside 2026: The Industry’s AI Turning Point
January 7, 2026
The life sciences sector is bracing for a year when AI delivers real returns, regulators move faster, and trial operations are finally built for modern science.
6 min read
False
Advertisement
Biopharma
Learnings from a Scope 1 and 2 Climate-Neutral Manufacturing Facility
By Sebastián Arana
December 30, 2025
Merck’s climate-neutral facility shows how sustainability, supply-chain transparency, and cultural change can scale low-carbon biomanufacturing and build long-term resilience.
2 min read
Addressing the Regulatory Documentation Bottleneck to Transform Drug Approvals
By Anita Modi
December 29, 2025
Agentic AI combined with human control points creates a new paradigm for accelerating documentation while maintaining regulatory integrity.
5 min read
The Post-Pandemic Evolution of Antiviral Research
December 22, 2025
The pandemic catalyzed a transformation in antiviral R&D. From better data to open collaboration, Tetiana Matviyuk of Enamine describes how the landscape has evolved.
3 min read
New Approach Methodologies: Why the Future of Drug Development Must Be Human
By Hayley Gooding
December 18, 2025
NAMs aren’t just a scientific upgrade, but a moral and practical necessity. The tools are ready. The question is: does the industry have the will to use them?
3 min read
How Mixing FSP and FSO Models Bring Agility to Modern Clinical Development
By Les Enterline
December 15, 2025
Clinical trials are becoming longer, costlier and more complex, but a growing number of sponsors are finding agility in a hybrid approach.
4 min read
Scratching the Surface of Microneedle Array Patches
By Andrew Riso
December 12, 2025
Why the industry should open its eyes to the benefits of microneedle array patches for drug delivery.
5 min read
Rebuilding Confidence in UK Pharma Manufacturing
By Martyn Williams
December 11, 2025
The UK’s pharma manufacturing base still has potential, but only if companies modernize operations, boost efficiency, and show global investors that the UK can compete on cost and capability.
6 min read
DSCSA in Action: Real-World Lessons from US Supply Chain Implementation
By Matt Sample
December 9, 2025
After a decade of preparation, the US pharmaceutical supply chain has seamless, serialized traceability for every prescription drug. Here are my lessons learned during that process.
3 min read
Drug Delivery is Biotech’s Blind Spot. Here’s How we Fix it With Excipients
By Lisa Stehno-Bittel
December 8, 2025
Drug delivery innovation lags behind molecule discovery. Smarter polymer-based excipients can boost biologic stability, efficacy, and accessibility, transforming patient outcomes and biotech success.
3 min read
